 |
| How is Neuroprotection Lost in the Parkinson’s Brain? |
| As we continue to honor Parkinson’s Awareness Month, we summarize a study utilizing novel anti-Parkin antibodies developed in a collaborative effort between The Michael J. Fox Foundation, Dr. Michael Schlossmacher’s lab, and BioLegend. Learn how scientists at the Ottawa Hospital Research Institute used these aggregate-preferring clones to elucidate novel neuroprotective functions of Parkin, and why these effects are lost during Parkinson’s disease. |
|
|
|
| 50% Discount on Anti-Parkin Antibodies |
| Interested in applying our new anti-Parkin clones to your own research? Detect both monomeric and aggregated Parkin with confidence, using our reliable anti-Parkin antibodies that are discounted 50% until the end of May 2020. |
|
|
|
| |
|
| |
|
|
Login/Register 
United States ($) USD
Austria (€) EUR
Belgium (€) EUR
Finland (€) EUR
France (€) EUR
Germany (€) EUR
Ireland (€) EUR
Japan (¥) JPY
Luxembourg (€) EUR
Netherlands (€) EUR
Switzerland (CHF) CHF
United Kingdom (£) GBP
Follow Us